Relationships are important — especially when there’s a massive effort to distribute COVID-19 vaccines under way. There have been reports recently, though, hinting that Pfizer‘s (NYSE: PFE) relationship with the U.S. government could be strained. In this Motley Fool Live video recorded on Dec. 18, 2020, healthcare and cannabis editor/analyst Olivia Zitkus and Fool.com writer Keith Speights discuss what’s behind the feud between Pfizer and the feds.
What’s Behind the Vaccine Feud Between Pfizer and the Feds?
Latest from Blog
It’s always hard to buy a stock that’s trading at an all-time high. Nobody wants to…
Image source: The Motley Fool. Kinder Morgan (NYSE: KMI)Q4 2020 Earnings CallJan 20, 2021, 4:30 p.m. ET Operator…
When should you claim Social Security? This is one of the most difficult questions to answer…
Image source: The Motley Fool. Hancock Whitney Corporation (NASDAQ: HWC)Q4 2020 Earnings CallJan 20, 2021, 5:00 p.m. ET…
With interest rates near all-time lows, retirees are looking further up the risk curve for income…